At a glance: Turmeric is the rhizome of Curcuma longa L. It contains curcuminoids—including curcumin—and a chemically distinct volatile oil fraction. “Turmeric”, “curcumin” and bioavailability-enhanced curcumin products are not interchangeable interventions. Research in osteoarthritis shows promising signals for some curcumin formulations, but formulation heterogeneity is substantial and current evidence does not justify claiming that turmeric is proven to treat inflammatory disease generally. Highly bioavailable curcumin formulations have also been associated with cases of liver injury.[1][2][3]
Botanical profile
- Accepted name: Curcuma longa L.
- Common names: turmeric, turmeric rhizome.
- Family: Zingiberaceae.
- Medicinal part: rhizome.
- EMA herbal drug name: Curcumae longae rhizoma.[1]
Like ginger, the medicinal part is a rhizome—an underground stem—not a true root. Turmeric is an important culinary spice as well as a medicinal plant, but dietary exposure and concentrated supplement exposure are not equivalent.
Major constituent groups
Two broad chemical groups are especially important:
- Curcuminoids, including curcumin, demethoxycurcumin and bisdemethoxycurcumin. These yellow polyphenolic pigments receive most research attention.
- Volatile oil constituents, including ar-turmerone, α- and β-turmerone and other sesquiterpenes, whose profile differs substantially from purified curcumin products.[4][5]
A purified curcumin capsule therefore does not chemically represent the whole rhizome, and turmeric essential oil is yet another preparation.
Traditional use
Turmeric has a long history in South Asian medicine and cooking. In Ayurvedic practice it has traditionally been used for sluggish digestion, abdominal discomfort, jaundice and other hepatobiliary complaints, as well as externally for wounds and skin problems. It has also been used for painful or stiff joints and muscles, menstrual complaints, and in warming formulas intended to support circulation and recovery after injury.
Contemporary herbal practice
Herbal practice usually treats whole turmeric rhizome as a warming digestive and musculoskeletal herb, while modern supplement practice often centres on concentrated curcuminoid extracts. Those are not the same intervention. A practitioner may use turmeric within a broader digestive or inflammatory formulation rather than chasing a single high curcumin number, and will take formulation, biliary history and concurrent medicines into account.
EMA regulatory assessment
The EMA HMPC has an EU herbal monograph for Curcuma longa rhizome in the gastrointestinal therapeutic area. Revision 1 was published in 2019, and the EMA published a final addendum to the assessment report in January 2026, updated in February 2026.[1]
As elsewhere in this library, an EU herbal monograph should not be translated into “EMA says turmeric treats everything it is marketed for”. The monograph concerns defined preparations and regulatory indications.
Turmeric versus curcumin
Curcumin is a constituent of turmeric, not another name for the plant. Many modern clinical trials use concentrated curcuminoid extracts, and some use specialised formulations intended to overcome curcumin’s relatively poor oral bioavailability.
Common strategies include lipid or phospholipid formulations, nanoparticles and combinations with piperine from black pepper, which can increase systemic exposure. Changing bioavailability may alter both potential effects and risks.[2]
Osteoarthritis: what does the clinical evidence say?
Several systematic reviews and meta-analyses have reported improvements in pain or function with turmeric or curcumin preparations in knee osteoarthritis. A 2024 meta-analysis of meta-analyses pooled 11 previous meta-analyses and reported improvements across several pain and WOMAC outcomes.[3]
However, this literature includes materially different formulations, curcuminoid concentrations, bioavailability strategies and trial designs. NCCIH characterises the initial osteoarthritis evidence as positive but states that higher-quality evidence is still needed and that the effect of bioavailability differences remains unclear.[2]
A more recent umbrella review likewise found efficacy signals but substantial methodological and clinical heterogeneity, with only a minority of included reviews rated high quality.[6]
What can reasonably be concluded?
The evidence supports continued investigation of defined curcumin formulations for osteoarthritis symptoms. It does not support collapsing the literature into “turmeric is a proven anti-inflammatory” or assuming that adding culinary turmeric to food reproduces a clinical-trial intervention.
Pharmacology
Curcuminoids have been studied extensively for effects on inflammatory signalling, oxidative stress and transcription pathways. Turmeric volatile oils also contain biologically active compounds and have their own experimental literature.[4][5]
The enormous preclinical literature is scientifically useful but creates a common evidence trap: an effect in a cell line at an experimentally achievable concentration may not occur after an ordinary oral dose in a person.
Bioavailability is not automatically better
Curcumin’s low systemic bioavailability has driven development of formulations designed to increase absorption. It is tempting to assume that “more bioavailable” must mean “more effective”. That has not been established across indications, and safety can change when exposure changes.
NCCIH specifically notes reports of liver damage in people taking some highly bioavailable curcumin products.[2]
Liver injury
Most people do not develop liver injury from turmeric, and conventionally formulated oral turmeric or curcumin appears to be tolerated by many users over short periods. Nevertheless, drug-induced liver injury associated with turmeric/curcumin supplements has become a recognised safety signal, particularly with formulations that enhance bioavailability.[2]
Symptoms such as jaundice, dark urine, marked fatigue, nausea or loss of appetite after starting a supplement require medical assessment rather than continuing the product because it is “natural”.
Other adverse effects
Reported adverse effects include nausea, vomiting, reflux, abdominal upset, diarrhoea and constipation. Topical curcumin can cause itching or urticaria in some people.[2]
Interactions
Interaction discussions around turmeric often outrun the clinical evidence. Laboratory studies suggest multiple possible enzyme, transporter and platelet effects, but the strength of evidence varies by preparation and medicine. Concentrated or bioavailability-enhanced products deserve more caution than culinary exposure.
Medication review is particularly sensible where someone uses anticoagulants or antiplatelet medicines, has gallbladder or hepatobiliary disease, takes medicines with narrow therapeutic ranges, or uses a formulation containing piperine or additional active ingredients.
Pregnancy and breastfeeding
Culinary turmeric in food is different from concentrated medicinal supplements. NCCIH advises that turmeric supplements may be unsafe in pregnancy and notes that little is known about medicinal amounts during breastfeeding.[2]
Student note: common evidence traps
- Turmeric, curcuminoid extract and purified curcumin are not synonyms.
- Record whether a formulation contains piperine or another bioavailability enhancer.
- Do not use an osteoarthritis meta-analysis as evidence for unrelated inflammatory diseases.
- Do not equate an in-vitro anti-inflammatory mechanism with human clinical efficacy.
- “Higher bioavailability” is a pharmacokinetic description, not proof of superior clinical benefit.
- Safety evidence from conventional preparations may not transfer cleanly to enhanced formulations.
- Separate culinary exposure from supplement-level medicinal exposure.
References
- European Medicines Agency, Committee on Herbal Medicinal Products. Curcumae longae rhizoma — Curcuma longa L., rhizoma. EU herbal monograph, assessment report and 2026 addendum. EMA. Revision 1 published 2019; final assessment-report addendum published January 2026 and updated February 2026.
- National Center for Complementary and Integrative Health. Turmeric: Usefulness and Safety. NCCIH. Updated April 2025; consulted September 2026.
- Bideshki MV, et al. The efficacy of curcumin in relieving osteoarthritis: a meta-analysis of meta-analyses. Phytotherapy Research. 2024;38(6):2875–2891. doi:10.1002/ptr.8153. PubMed.
- Review of sources, morphology, phytochemistry and pharmacology of Curcuma longa rhizome and related medicinal Curcuma materials. Frontiers in Pharmacology. 2023;14:1229963. PubMed.
- Dosoky NS, Setzer WN. Chemical composition and biological activities of essential oils of Curcuma species. Nutrients. 2018;10(9):1196. doi:10.3390/nu10091196. PubMed.
- Efficacy and safety of different curcumin formulations in osteoarthritis: an umbrella review of systematic reviews. 2026. PubMed.
Additional materia medica sources
- ESCOP. Curcumae longae rhizoma — Turmeric rhizome, ESCOP Monographs.
- Blumenthal M, et al., eds. The Complete German Commission E Monographs. American Botanical Council; 1998.
- World Health Organization. Technical and medicinal-plant reviews addressing Curcuma longa.
- Mills S, Bone K. Principles and Practice of Phytotherapy. 2nd ed. Elsevier; 2013.
Last reviewed: 20 September 2026. Educational reference only; not an individual dosing or prescribing guide.
← Return to the Herbal Monograph Library | Herbal Medicine Safety and Interactions